Prevent effects of iron overload in patients with hereditary haemochromatosis (HH) by early genetic testing and treatment initiation.

Hereditary haemochromatosis is one of the most prevalent genetic disorders in the Northern European population. It is characterized by progressive accumulation of iron in various organs. ViennaLab assays identify the most frequent genetic variants causing iron overload.

 

Haemochromatosis

 

  • Hereditary haemochromatosis (HH) is an inherited iron overload disorder characterized by excessive absorption and deposition of iron.
  • HH is caused by mutations in the HFE, TFR2 or FPN1 genes.
  • Over time, iron deposition can lead to dysfunction and failure in multiple organs.
  • If left untreated, HH can lead to liver cirrhosis, liver cancer, diabetes, arthritis, and cardiopathies.
  • The primary goal in the management of HH is to identify patients and initiate treatment before irreversible damage occurs.
  • Therefore, early diagnosis and treatment initiation are essential to allow a virtually normal life for affected individuals.

Link to ACG Clinical Guideline

 

ProductREFUnit SizeIFUBrochure
Haemochromatosis StripAssay® A4-22020 tests

PDF

PDF

Haemochromatosis StripAssay® B4-21020 tests

PDF

PDF

HFE C282Y RealFast™ Assay7-130
7-133
100 rxn
32 rxn

PDF

HFE H63D RealFast™ Assay7-140
7-143
100 rxn
32 rxn

PDF

HFE mpx RealFast™ Assay7-135
7-138
100 rxn
32 rxn

PDF